What is the optimal concentration and dose of cidofovir for intralesional administration in treating recurrent respiratory papillomatosis?
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866901611075338240 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Intralesional cidofovir is typically used at concentrations between 5 mg/mL and 7.5 mg/mL for treating recurrent respiratory papillomatosis, but dosing standards and optimal regimens remain variable and not well-established. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17766724 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What is the optimal concentration and dose of cidofovir for intralesional administration in treating recurrent respiratory papillomatosis? Tripdatabase optimal concentration dose cidofovir intralesional administration treating recurrent respiratory papillomatosis Intralesional cidofovir is typically used at concentrations between 5 mg/mL and 7.5 mg/mL for treating recurrent respiratory papillomatosis, but dosing standards and optimal regimens remain variable and not well-established. |
| title | What is the optimal concentration and dose of cidofovir for intralesional administration in treating recurrent respiratory papillomatosis? |
| topic | optimal concentration dose cidofovir intralesional administration treating recurrent respiratory papillomatosis |
| url | https://doi.org/10.5281/zenodo.17766724 |